Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma

Oncology

Volumn 70, Issue 3, 2006, Pages 168-172

  Sterian, Anca ^a   Kan, Takatsugu ^a   Berki, Agnes T ^a   Mori, Yuriko ^a,b   Olaru, Andreea ^a,b   Schulmann, Karsten ^c   Sato, Fumiaki ^a,b   Wang, Suna ^a   Paun, Bogdan ^a   Cai, Kun ^a   Hamilton, James P ^a   Abraham, John M ^a   Meltzer, Stephen J ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cancer; CARF; Chromosome 4q; Esophagus; hCDC4; LOH; Mutation

Indexed keywords

ALLELE; ARTICLE; CANCER MORTALITY; CARCINOGENESIS; CARF GENE; CHROMOSOME 4Q; CHROMOSOME ARM; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; GENE DELETION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HCDC4 GENE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 4; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL NEOPLASMS; F-BOX PROTEINS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 33746628060     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094444     Document Type: Article

References (41)

1. Moskaluk CA, Hu J, Perlman EJ: Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes Cancer 1998;22:305-311.
2. El-Rifai W, Harper JC, Cummings OW, et al: Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res 1998;58:34-37.
3. Hammoud ZT, Kaleem Z, Cooper JD, Sundaresan RS, Patterson GA, Goodfellow PJ: Allelo-type analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res 1996;56:4499-4502.
4. Sironi E, Cerri A, Tomasini D, et al: Loss of heterozygosity on chromosome 4q32-35 in sporadic basal cell carcinomas: evidence for the involvement of p33ING2/ING1L and SAP30 genes. J Cutan Pathol 2004;31:318-322.
5. Shivapurkar N, Maitra A, Milchgrub S, Gazdar AF: Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum Pathol 2001;32:169-177.
6. Sherwood JB, Shivapurkar N, Lin WM, et al: Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants. Gynecol Oncol 2000;79:90-96.
7. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM: Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 1991;88:5635-5639.
8. Obata M, Lee GH, Kanda H, Kitagawa T, Ogawa K: Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts. Mol Carcinog 1997;19:17-24.
9. McGowan-Jordan IJ, Speevak MD, Blakey D, Chevrette M: Suppression of tumorigenicity in human teratocarcinoma cell line PA-1 by introduction of chromosome 4. Cancer Res 1994;54:2568-2572.
10. Spruck CH, Strohmaier H, Sangfelt O, et al: hCDC4 gene mutations in endometrial cancer. Cancer Res 2002;62:4535-4539.
11. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI: Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001;413:316-322.
12. Cassia R, Moreno-Bueno G, Rodriguez-Perales S, Hardisson D, Cigudosa JC, Palacios J: Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. J Pathol 2003;201:589-595.
13. Ekholm-Reed S, Spruck CH, Sangfelt O, et al: Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res 2004;64:795-800.
14. Calhoun ES, Jones JB, Ashfaq R, et al: BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am J Pathol 2003;163:1255-1260.
15. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK: Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 2001;413:311-316.
16. Rajagopalan H, Jallepalli PV, Rago C, et al: Inactivation of hCDC4 can cause chromosomal instability. Nature 2004;428:77-81.
17. Wadhwa R, Sugihara T, Hasan MK, Duncan EL, Taira K, Kaul SC: A novel putative collaborator of p19ARF. Exp Gerontol 2003;38:245-252.
18. Hasan MK, Yaguchi T, Minoda Y, et al: Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control. Biochem J 2004;380(pt 3):605-610.
19. Olaru A, Mori Y, Yin J, et al: Loss of heterozygosity and mutational analyses of the ACT-RII gene locus in human colorectal tumors. Lab Invest 2003;83:1867-1871.
20. Loughran O, Clark LJ, Bond J, et al: Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 1997;14:1955-1964.
21. Piao Z, Park C, Park JH, Kim H: Deletion mapping of chromosome 4q in hepatocellular carcinoma. Int J Cancer 1998;79:356-360.
22. Sibley K, Cuthbert-Heavens D, Knowles MA: Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. Oncogene 2001;20:686-691.
23. Cho ES, Chang J, Chung KY, Shin DH, Kim YS, Kim SK: Identification of tumor suppressor loci on the long arm of chromosome 4 in primary small cell lung cancers. Yonsei Med J 2002;43:145-151.
24. Hu N, Roth MJ, Polymeropolous M, et al: Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer 2000;27:217-228.
25. Rosin MP, Cheng X, Poh C, et al: Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000;6:357-362.
26. Dohner H, Bloomfield CD, Frizzera G, Frestedt J, Arthur DC: Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosomes Cancer 1992;5:392-398.
27. Bluteau O, Beaudoin JC, Pasturaud P, et al: Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping. Oncogene 2002;21:1225-1232.
28. Hu J, Jiang C, Ng HK, Pang JC, Tong CY, Chen S: Genome-wide allelotype study of primary glioblastoma multiforme. Chin Med J (Engl) 2003;116:577-583.
29. Kumpel CA, Powell SM, Moskaluk CA: Mapping of genetic deletions on the long arm of chromosome 4 in human esophageal adenocarcinomas. Am J Pathol 1999;154:1329-1334.
30. Hasan MK, Yaguchi T, Sugihara T, et al: CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53. J Biol Chem 2002;277:37765-37770.
31. Quelle DE, Zindy F, Ashmun RA, Sherr CJ: Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
32. Kamijo T, Zindy F, Roussel MF, et al: Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91:649-659.
33. Stott FJ, Bates S, James MC, et al: The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998;17:5001-5014.
34. Wynford-Thomas D, Jones CJ, Wyllie FS: The tumour suppressor gene p53 as a regulator of proliferative life-span and tumour progression. Biol Signals 1996;5:139-153.
35. von Zglinicki T, Saretzki G: Molecular mechanisms of senescence in cell culture (in German). Z Gerontol Geriatr 1997;30:24-28.
36. Prives C, Hall PA: The p53 pathway. J Pathol 1999;187:112-126.
37. Duncan EL, Reddel RR: Genetic changes associated with immortalization. A review. Biochemistry (Mosc) 1997;62:1263-1274.
38. Bringold F, Serrano M: Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 2000;35:317-329.
39. Eymin B, Leduc C, Coll JL, Brambilla E, Gazzeri S: p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice. Oncogene 2003;22:1822-1835.
40. Shao JY, Wang HY, Huang XM, et al: Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol 2000;17:1267-1275.
41. Hoang MP, Maitra A, Gazdar AF, Albores-Saavedra J: Primary mammary small-cell carcinoma: a molecular analysis of 2 cases. Hum Pathol 2001;32:753-757.